Christopher T. Walsh '65 and Ernest G. Cravalho recently became associate directors of the Whitaker College of Health Sciences, Technology, and Management, at the Massachusetts Institute of Technology (MIT), Irving M. London '39, director of Whitaker, said yesterday.
Walsh and Cravalho will aid London in managing the Harvard-MIT Division of Health Sciences and Technology (HST) and organizing new programs in the health sciences at MIT.
Students take classes at both schools and receive either an M.D. degree from Harvard Medical School or a Ph. D. degree from MIT.
Walsh holds professorships in both chemistry and biology at MIT and received the Eli Lilly Award in Biological Chemistry in 1978 for his work on enzyme mechanisms. His research interests include molecular pharmacology and medicinal chemistry.
Cravalho, Matsushita Professor of Mechanical Engineering in Medicine at MIT and associate director of HST is one of the leading experts in the preservation of tissues at extremely low temperatures.
A $29 million medical complex, now under construction at MIT, will house Whitaker, when the building is completed in 1981.
Students' Start-Ups Help Fuel High-Tech Boom in CambridgeHarvard students who want to get involved in Internet start-ups have come to the right place. Student start-up companies are
Draper Lab Retains MIT ConnectionThis is the second in a two-part series. Although the Massachusetts Institute of Technology (MIT) formally disassociated itself from Draper
Harvard May Decide to Hire University's First PatrolwomanHarvard may soon add a woman to the now all-male University Police Force, following the lead of MIT and Tufts
MIT-Related Firms Driving Biotech IndustryCambridge (AP)--The booming field of biotechnology can trace much of its success to research and graduates of the Massachusetts Institute
MIT Chooses New PresidentThe Massachusetts Institute of Technology (MIT) Corporation yesterday elected Paul E. Gray, MIT's chancellor since 1971, as the MIT's 14th
Harvard Lags in Tech TransfersHarvard is the world’s leading university in biotech research, but lags far behind MIT in converting its ideas into marketable